Showing results (11-20 of 136) with videos related to
Sort By:
Pageof 14
Archives of Dermatology|November 17, 2010
Thyrotoxicosis with pegylated interferon alfa-2bSarah A Lowndes, Ruth Asher, Mark R MiddletonTherapeutic Advances in Medical Oncology|January 17, 2013
New treatment approaches in melanoma: current research and clinical prospectsMilap G Rughani, Avinash Gupta, Mark R MiddletonTargeted Oncology|February 10, 2016
Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case ReportAndrew J Dooley, Avinash Gupta, Mark R MiddletonCancer Investigation|January 23, 2004
Health-related quality of life in patients with advanced metastatic melanoma: results of a randomized phase III study comparing temozolomide with dacarbazineGwendoline M Kiebert, Deborah L Jonas, Mark R MiddletonTherapeutic Advances in Medical Oncology|November 4, 2014
Intermittent dosing with vemurafenib in BRAF V600E-mutant melanoma: review of a case seriesAndrew J Dooley, Avinash Gupta, Madhumita Bhattacharyya, et al.European Journal of Endocrinology|April 13, 2012
Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and reviewAgata Juszczak, Avinash Gupta, Niki Karavitaki, et al.Critical Reviews in Oncology/Hematology|February 8, 2012
Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research?Esme J Hill, Nils H Nicolay, Mark R Middleton, et al.International Journal of Clinical Oncology|June 11, 2026
BRAF-targeted therapy in non-melanomatous BRAF-mutant tumours: a systematic review of broad but histology-modulated efficacyYael R Lefkovits, Luke S McLean, Mark R Middleton, et al.Cancer Treatment and Research|May 13, 2022
Lag3: From Bench to BedsideFrancesca Aroldi, Reem Saleh, Insiya Jafferji, et al.BMC Cancer|January 6, 2021
Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysisKabirraaj Toor, Mark R Middleton, Keith Chan, et al.Pageof 14